tradingkey.logo
tradingkey.logo
Pesquisar

Haleon PLC

HLN
Adicionar à lista de desejos
9.110USD
-0.185-1.99%
Fechamento 05/08, 16:00ETCotações atrasadas em 15 min
40.08BValor de mercado
33.07P/L TTM

Mais detalhes de Haleon PLC Empresa

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Informações de Haleon PLC

Código da empresaHLN
Nome da EmpresaHaleon PLC
Data de listagemJul 18, 2022
CEOMcnamara (Brian)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscalJul 18
EndereçoBuilding 5, First Floor
CidadeWEYBRIDGE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited Kingdom
Código postalKT13 0NY
Telefone441932822000
Sitehttps://www.haleon.com/
Código da empresaHLN
Data de listagemJul 18, 2022
CEOMcnamara (Brian)

Executivos da empresa Haleon PLC

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dame Vivienne Cox
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Asmita Dubey
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Amanda J. Mellor
Ms. Amanda J. Mellor
Company Secretary
Company Secretary
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Oral health
3.46B
31.38%
Pain relief
2.56B
23.25%
Respiratory health
1.87B
16.98%
Vitamins, minerals and supplements
1.69B
15.28%
Digestive health and other
987.00M
8.95%
Therapeutic Skin Health and Other
460.00M
4.17%
Por RegiãoUSD
Nome
Receita
Proporção
Rest of the World
6.19B
56.11%
EMEA and LatAm
4.59B
41.63%
Northern America
3.87B
35.05%
US & Puerto Rico
3.47B
31.44%
APAC
2.57B
23.32%
Outro
-9.66B
-87.55%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Oral health
3.46B
31.38%
Pain relief
2.56B
23.25%
Respiratory health
1.87B
16.98%
Vitamins, minerals and supplements
1.69B
15.28%
Digestive health and other
987.00M
8.95%
Therapeutic Skin Health and Other
460.00M
4.17%

Distribuição de ações

Atualizado em: sex, 24 de abr
Atualizado em: sex, 24 de abr
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dodge & Cox
3.42%
Fidelity Management & Research Company LLC
2.08%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
Outro
93.06%
Investidores
Investidores
Proporção
Dodge & Cox
3.42%
Fidelity Management & Research Company LLC
2.08%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
Outro
93.06%
Tipos de investidores
Investidores
Proporção
Investment Advisor
5.54%
Investment Advisor/Hedge Fund
5.37%
Research Firm
0.86%
Hedge Fund
0.64%
Sovereign Wealth Fund
0.36%
Bank and Trust
0.17%
Family Office
0.06%
Family Office
0.06%
Family Office
0.06%
Outro
86.87%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
1090
575.83M
12.97%
+12.05M
2025Q4
1068
546.97M
12.28%
-32.09M
2025Q3
1049
570.14M
12.80%
-16.29M
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
151.76M
3.4%
-2.63M
-1.70%
Dec 31, 2025
Fidelity Management & Research Company LLC
92.14M
2.07%
+3.03M
+3.39%
Dec 31, 2025
ClearBridge Investments, LLC
31.42M
0.7%
-1.92M
-5.77%
Dec 31, 2025
Harding Loevner LP
16.62M
0.37%
-1.29M
-7.22%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
16.18M
0.36%
+15.90M
+5781.82%
Dec 31, 2025
Fidelity Institutional Asset Management
12.09M
0.27%
+701.80K
+6.16%
Dec 31, 2025
Sculptor Capital Management, Inc
10.45M
0.23%
+505.00K
+5.08%
Dec 31, 2025
Ostrum Asset Management
10.00M
0.22%
+8.12M
+429.78%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
9.23M
0.21%
+1.53M
+19.85%
Dec 31, 2025
Parametric Portfolio Associates LLC
8.24M
0.18%
+681.07K
+9.01%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
VanEck Pharmaceutical ETF
6.34%
Franklin ClearBridge Enhanced Income ETF
1.87%
One Global ETF
0.65%
ActivePassive International Equity ETF
0.33%
SP Funds S&P World (ex-US) ETF
0.27%
Avantis Responsible International Equity ETF
0.13%
Avantis International Equity ETF
0.08%
Avantis International Large Cap Value ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
Fidelity Blue Chip Value ETF
0%
Ver Mais
VanEck Pharmaceutical ETF
Proporção6.34%
Franklin ClearBridge Enhanced Income ETF
Proporção1.87%
One Global ETF
Proporção0.65%
ActivePassive International Equity ETF
Proporção0.33%
SP Funds S&P World (ex-US) ETF
Proporção0.27%
Avantis Responsible International Equity ETF
Proporção0.13%
Avantis International Equity ETF
Proporção0.08%
Avantis International Large Cap Value ETF
Proporção0%
Unusual Whales Subversive Democratic Trading ETF
Proporção0%
Fidelity Blue Chip Value ETF
Proporção0%

Dividendo

Um total de 570.00M USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Feb 26, 2026
HLN.NB Approximate final Cash Dividend of gross USD 0.130732 paid on May 14, 2026 going ex on Apr 10, 2026
Apr 10, 2026
May 14, 2026
Apr 10, 2026
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI